Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

Market Cap	5.21B
Revenue (ttm)	2.13B
Net Income (ttm)	259.93M
Shares Out	401.93M
EPS (ttm)	0.63
PE Ratio	20.62
Forward PE	n/a
Dividend	0.34 (2.63%)
Ex-Dividend Date	Jun 26, 2025

Volume	13,251,800
Average Volume	13,952,703
Open	12.90
Previous Close	12.95
Day's Range	12.74 - 12.96
52-Week Range	10.69 - 16.50
Beta	0.63
RSI	57.76
Earnings Date	Aug 28, 2025

About SHA:603439

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular drugs, injury by fall medication, rehabilitation medicine, GI medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Anshun, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 2,852
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603439

Financial Performance

In 2024, SHA:603439's revenue was 2.14 billion, an increase of 31.16% compared to the previous year's 1.63 billion. Earnings were 274.03 million, a decrease of -6.38%.